15. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813 8. 16. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527 33. 17. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes asso- ciated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301:937 44. 18. Lau WC, Gurbel PA. The drug-drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:699 700. 19. Mega JL, Close SL, Wiviott SD, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354 62. 20. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, American Heart Association, Society for Cardiovascular Angiography and Interventions, et al. ACCF/AHA clopi- dogrel clinical alert: approaches to the FDA boxed warning. Circulation. 2010;122:537 57. 21. Collet JP, Hulot JS, Pena A, et al. Cytochrome P450 2C19 poly- morphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet. 2009;373:309 17. 22. Giusti B, Gori AM, Marcucci R, et al. Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol. 2009;103:806 11. 23. Roden DM, Stein CM. Clopidogrel and the concept of high-risk phar- macokinetics. Circulation. 2009;119:2127 30. 24. Sibbing D, Stegherr J, Latz W, et al. Cytochrome P450 2C19 loss-of- function polymorphism and stent thrombosis following percutaneous coronary intervention. Eur Heart J. 